StockWatch
·
Pharmaceuticals
Board Meeting7 Aug 2026, 02:35 pm

Cresanto Global Board Meeting on Aug 13 to Approve Q1 FY27 Results

AI Summary

Cresanto Global Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda items include the consideration and approval of the un-audited financial results for the first quarter ended June 30, 2026, and the associated Limited Review Report. Additionally, the board will discuss a change in the company's corporate office and the location for maintaining its books of accounts. A trading window closure for designated persons will be in effect from July 1, 2026, until 48 hours after the results declaration.

Key Highlights

  • Board meeting scheduled for August 13, 2026.
  • To approve un-audited financial results for Q1 FY27.
  • Limited Review Report for Q1 FY27 to be considered.
  • Change in corporate office location to be discussed.
  • Insider trading window closure from July 1, 2026.